Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

dc.contributor.authorLiaw, Yun-Fan
dc.contributor.authorSung, Joseph J Y
dc.contributor.authorChow, Wan Cheng
dc.contributor.authorFarrell, Geoffrey
dc.contributor.authorLee, Cha-Ze
dc.contributor.authorYuen, Hon
dc.contributor.authorTanwandee, Tawesak
dc.contributor.authorTao, Qi-Min
dc.contributor.authorShue, Kelly
dc.contributor.authorKeene, Oliver N
dc.date.accessioned2015-12-10T22:14:14Z
dc.date.issued2004
dc.date.updated2015-12-09T08:05:33Z
dc.description.abstractBACKGROUND: The effectiveness of antiviral therapy in preventing disease progression in patients with chronic hepatitis B and advanced fibrosis or cirrhosis is unknown. METHODS: Patients with chronic hepatitis B who had histologically confirmed cirrhosis
dc.identifier.issn0028-4793
dc.identifier.urihttp://hdl.handle.net/1885/50198
dc.publisherMassachusetts Medical Society
dc.sourceNew England Journal of Medicine
dc.subjectKeywords: alanine aminotransferase; albumin; alpha fetoprotein; aspartate aminotransferase; bilirubin; hepatitis B surface antigen; hepatitis B(e) antibody; hepatitis B(e) antigen; lamivudine; placebo; virus DNA; abdominal pain; adolescent; adult; aged; article; ba
dc.titleLamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
dc.typeJournal article
local.bibliographicCitation.issue15
local.bibliographicCitation.lastpage1531
local.bibliographicCitation.startpage1521
local.contributor.affiliationLiaw, Yun-Fan, University of Taipei
local.contributor.affiliationSung, Joseph J Y, Prince of Wales Hospital
local.contributor.affiliationChow, Wan Cheng, Singapore General Hospital
local.contributor.affiliationFarrell, Geoffrey, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationLee, Cha-Ze, University Hospital, Tapei
local.contributor.affiliationYuen, Hon, Princess Margaret Hospital
local.contributor.affiliationTanwandee, Tawesak, Siriraj Hospital
local.contributor.affiliationTao, Qi-Min, People's Hospital
local.contributor.affiliationShue, Kelly, GlaxoSmithKline
local.contributor.affiliationKeene, Oliver N, GlaxoSmithKline
local.contributor.authoruidFarrell, Geoffrey, u4028700
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110300 - CLINICAL SCIENCES
local.identifier.ariespublicationu4222028xPUB199
local.identifier.citationvolume351
local.identifier.doi10.1056/NEJMoa033364
local.identifier.scopusID2-s2.0-19544391413
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Liaw_Lamivudine_for_Patients_with_2004.pdf
Size:
110.59 KB
Format:
Adobe Portable Document Format